SCHEMBL7991885

SCHEMBL7991885

Cc1ccc(CC(O)CN)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2A6 P11509 1/20 0.46
GRIN2D O15399 3/20 0.40
GRIN3B O60391 3/20 0.40
ADRA1A P35348 3/20 0.40
GRIN1 Q05586 3/20 0.40
GRIN2A Q12879 3/20 0.40
GRIN2B Q13224 3/20 0.40
GRIN2C Q14957 3/20 0.40
GRIN3A Q8TCU5 3/20 0.40
AGXT P21549 2/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1B P35368 1/20 0.40
IDO1 P14902 3/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 1/20 0.38
HCRTR2 O43614 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30556750 0.86 IDO1 (0.46) TAAR1CYP1A2CYP2A6GRIN2DGRIN3B
SCHEMBL18779904 0.80 GRIN2D (0.41) TAAR1CYP1A2CYP2A6GRIN2DGRIN3B
SCHEMBL14402400 0.80 GRIN2D (0.41) TAAR1CYP1A2CYP2A6GRIN2DGRIN3B
SCHEMBL5936696 0.80 CYP3A4 (0.46) TAAR1CYP1A2CYP2A6GRIN2DGRIN3B
SCHEMBL27465388 0.80 LOXL2 (0.48) CYP1A2CYP2D6CYP2C19
SCHEMBL26238707 0.80 GRIN2D (0.41) TAAR1CYP1A2CYP2A6GRIN2DGRIN3B
SCHEMBL11827547 0.78 PPARG (0.42) TAAR1CYP1A2CYP2A6GRIN2DGRIN3B
SCHEMBL3053218 0.78 IDO1 (0.50) TAAR1CYP1A2CYP2A6GRIN2DGRIN3B
SCHEMBL6605532 0.78 HTR2A (0.46) TAAR1CYP1A2GRIN2DGRIN3BADRA1A
SCHEMBL16434845 0.78 LOXL2 (0.50) TAAR1CYP1A2AGXTIDO1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7163935-B2 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2007-01-16 US disclosed
US-6288224-B1 Preparation of n-arylmethyl aziridine derivatives, 1,4,7,10-tetraazacyclododecane derivatives obtained therefrom and n-arylethyl-ethanolamine sulphonate esters as intermediates NYCOMED SALUTAR, INC. 2001-09-11 US disclosed
US-6048979-A CYCLOTETRAMERIZING, CLEAVAGE OF ARYLMETHYL GROUPS TO PREPARE CYCLEN AND DERIVATIVES NYCOMED SALUTAR, INC. (US) 2000-04-11 US disclosed
CN-1181751-A Prepn. of N-arylmethyl axiridine derivatives, 1, 4, 7, 10 -Tetraazacyclododecane derivatives obtained therefrom and N -arylmethyl -ethanol -amine sulphonate esters as intermediates NYCOMED SALUTAR INC (US) 1998-05-13 CN disclosed
EP-0813523-A2 PREPARATION OF N-ARYLMETHYL AZIRIDINE DERIVATIVES, 1,4,7,10-TETRAAZACYCLODODECANE DERIVATIVES OBTAINED THEREFROM AND N-ARYLMETHYL-ETHANOL-AMINE SULPHONATE ESTERS AS INTERMEDIATES NYCOMED SALUTAR, INC. (US) 1997-12-29 EP disclosed
WO-1996028420-A2 PREPARATION OF N-ARYLMETHYL AZIRIDINE DERIVATIVES, 1,4,7,10-TETRAAZACYCLODODECANE DERIVATIVES OBTAINED THEREFROM AND N-ARYLMETHYL-ETHANOL-AMINE SULPHONATE ESTERS AS INTERMEDIATES NYCOMED SALUTAR, INC. (US) 1996-09-19 WO disclosed
US-4154837-A ANTIARRHYTHMIC, ADRENERGIC BLOCKING AGENTS, ANTIANGINOUS BOEHRINGER INGELHEIM GMBH (DE) 1979-05-15 US disclosed